Cartesian Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAC and other ETFs, options, and stocks.

About RNAC

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. 

CEO
Carsten Brunn
CEOCarsten Brunn
Employees
66
Employees66
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
Founded
Employees
66
Employees66

RNAC Key Statistics

Market cap
352.98M
Market cap352.98M
Price-Earnings ratio
-0.26
Price-Earnings ratio-0.26
Dividend yield
—
Dividend yield—
Average volume
83.93K
Average volume83.93K
High today
$13.60
High today$13.60
Low today
$12.60
Low today$12.60
Open price
$13.05
Open price$13.05
Volume
66.13K
Volume66.13K
52 Week high
$26.50
52 Week high$26.50
52 Week low
$8.46
52 Week low$8.46

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own RNAC. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
Tilray Brands
SNDL
NIO
Aurora Cannabis
Nokia
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.